Single Protein Encapsulated SN38 for Tumor-Targeting Treatment

BACKGROUND: The alkaloid camptothecin analog SN38 is a potent antineoplastic agent, but cannot be used directly for clinical application due to its poor water solubility. Currently, the prodrug approach on SN38 has resulted in 3 FDA-approved cancer therapeutics, irinotecan, ONIVYDE, and Trodelvy. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Changjun J., Huang, Faqing, Wang, Kinsley, Liu, Mengmeng, Chow, Warren A., Ling, Xiang, Li, Fengzhi, Causey, Jason L., Huang, Xiuzhen, Cook-Wiens, Galen, Cui, Xiaojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402254/
https://www.ncbi.nlm.nih.gov/pubmed/37546894
http://dx.doi.org/10.21203/rs.3.rs-3154635/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402254/
https://www.ncbi.nlm.nih.gov/pubmed/37546894
http://dx.doi.org/10.21203/rs.3.rs-3154635/v1

Ejemplares similares